PATH vs XRAY
Uipath Inc (PATH) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PATH and XRAY stock pages for the full models.
Not investment advice.